Other
Clinique Saint Joseph, Liège
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
Failure Rate
20.0%
1 terminated/withdrawn out of 5 trials
Success Rate
66.7%
-19.8% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 2(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT02914717Completed
The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis
Role: collaborator
NCT05302115Unknown
S-ICD French Cohort Study (HONEST)
Role: collaborator
NCT04251572Not ApplicableUnknown
HCV Reinfection After DAA Therapy in PWID in Belgium
Role: collaborator
NCT02958163Phase 2Terminated
Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)
Role: collaborator
NCT00830778Phase 3Completed
Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy
Role: collaborator
All 5 trials loaded